CClinicalTrials.gg
CompletedNCT02989246EOBventUpdated Oct 30, 2024Results posted

Effort of Breathing Guided Ventilator Protocol

An interventional study of Ventilator protocol and Esophageal Catheter in Ventilators, Mechanical and Work of Breathing, sponsored by Children's Hospital Los Angeles. Completed at 1 site in United States. Open to participants aged 37 Weeks to 18 Years. Per ClinicalTrials.gov, last updated 2024-10-30.

Sponsored by Children's Hospital Los Angeles · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Not applicable
Ages
37 Weeks to 18 Years
Sex
All
01

Study summary

This pilot study tests the feasibility of using a computerized ventilator management protocol seeking to encourage lung protective ventilation during the acute phase of ventilation, and esophageal manometry based titration of ventilator settings during the weaning phase of ventilation, for children with acute respiratory failure. The investigators hypothesize that such an approach will reduce time on mechanical ventilation, largely by preserving diaphragm muscle function.

Read the detailed description

Objectives: This pilot study will help refine a computer based ventilator management protocol which will be used in both acute and weaning phases of ventilation for children with acute respiratory failure. The acute phase protocol is an adaptation of the Acute Respiratory Distress Syndrome Network protocol for pediatrics, and the weaning phase involves an esophageal manometry guided weaning protocol based on effort of breathing. The investigators seek to test the safety and feasibility of the protocol recommendations and the software system , and help determine the potential effect size of the intervention to determine feasibility of a randomized controlled trial. They also seek to determine the feasibility and reproducibility of serial diaphragm ultrasound measurements on mechanically ventilated children.

Study Population: All children intubated and mechanically ventilated in the Children's Hospital Los Angeles Pediatric ICU with an anticipated length of intubation > 48 hours will be eligible, with some exclusion criteria based on ability to perform the measurements.

Study methodology: After consent, an esophageal catheter will be placed. A software management tool for ventilator management will be placed at the bedside for each enrolled patient, and recommendations regarding changing ventilator support will be provided to the clinicians every several hours during both acute and weaning phases. When ventilator support is below a threshold, recommendations will be made to perform spontaneous breathing trials. The clinicians will ultimately decide whether to accept or reject the recommendations, and will evaluate the patient before each potential change to the ventilator. The acceptance or rejection of recommendations will be tracked, and used to refine the intervention. Daily diaphragm ultrasound measurements will also be obtained to monitor diaphragm thickness and contractile activity.

Follow up: Clinical outcomes will be followed while in the ICU including re-intubation, medications administered, and ICU length of stay. No follow up after ICU discharge is planned.

Analysis plans: Data will be used to refine the intervention, test the acceptability of protocol recommendations to bedside providers, and determine sample size estimates for a follow up randomized controlled trial. These analyses will be descriptive. A pilot of 40 patients is anticipated.

02

Conditions studied

  • Ventilators, Mechanical
  • Work of Breathing

Keywords

  • pediatrics
  • ventilator weaning
03

In context

Respiratory Aspiration

1,092 studies on the registry are indexed under Respiratory Aspiration; 216 are open to participants now.

This study's enrollment of 32 is below the median of 42 across 881 interventional studies indexed under Respiratory Aspiration.

Browse Respiratory Aspiration studies →

Lead sponsor

Children's Hospital Los Angeles is the lead sponsor of 150 studies on the registry; 46 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
37 Weeks to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Intubated and mechanically ventilated patients in the Children's Hospital Los Angeles Pediatric ICU
  • Anticipated length of intubation > 48 hours.
  • The primary attending physician approves use of the protocol on the patient.

Exclusion criteria

Exclusion Criteria:

  • Corrected gestational age less than 37 weeks
  • Contraindications to nasoesophageal catheter placement (nasopharyngeal or esophageal abnormalities) or Respiratory Inductance Plethysmography bands (abdominal wall defects such as omphalocele).
  • Significant lower airway obstruction (asthma or bronchiolitis), confirmed by ventilator spirometry
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Intervention Arm

    Ventilator management using the proposed protocol in both acute and weaning phases. Patients will be managed according the the Ventilator protocol using the esophageal catheter for the weaning phase

    Other: Ventilator protocol · Device: Esophageal Catheter

Interventions

  • OtherVentilator protocol

    Open loop ventilator management by a computer based protocol

  • DeviceEsophageal Catheter

    Esophageal manometry measurements of patient effort of breathing will be used to guide the protocol recommendations

06

What researchers measure

Primary outcomes

  1. Percentage of Protocol Recommendations Which Are Accepted by the Clinical Provider

    The investigators will track the percentage of recommendations which are accepted by providers, as well as the reasons why recommendations were not accepted

    Time frame: With each protocol recommendation, approximately every 4 hours during the course of mechanical ventilation (up to 28 days)

07

Results

Posted Oct 22, 2021

Participant flow

Participant flow — Overall Study
MilestoneIntervention Arm
Started32
Completed32
Not completed0

Outcome measures

PrimaryPercentage of Protocol Recommendations Which Are Accepted by the Clinical Provider

The investigators will track the percentage of recommendations which are accepted by providers, as well as the reasons why recommendations were not accepted

Time frame:
With each protocol recommendation, approximately every 4 hours during the course of mechanical ventilation (up to 28 days)
Reported as:
Mean · percentage adherant
Percentage of Protocol Recommendations Which Are Accepted by the Clinical Provider
percentage adherantIntervention Arm
Percentage of Protocol Recommendations Which Are Accepted by the Clinical Provider76 (74.8 to 77.9)

Adverse events

Collected over During ICU admission. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention Arm7/32 (21.9%)0/32 (0%)0/32 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(months)Intervention Arm
Median100.7 (30.7 to 150.4)
Sex: Female, Male
Sex: Female, Male(Participants)Intervention Arm
Female13
Male19
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Intervention Arm
Region of Enrollment
Region of Enrollment(participants)Intervention Arm
United States32
08

Study locations

1 site
  • Children's Hospital Los Angeles
    Los Angeles, California 90027, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 2, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02989246
Lead sponsor
Children's Hospital Los Angeles
Responsible party
Robinder Khemani (Principal Investigator, Children's Hospital Los Angeles) — Principal investigator
First posted
Dec 12, 2016
Start date
Feb 1, 2015
Primary completion
Oct 18, 2017
Completion
Dec 1, 2018
Results posted
Oct 22, 2021
Last update
Oct 30, 2024

Study contacts

Robinder Khemani, MD
principal investigator · Children's Hospital Los Angeles

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion